BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 7, 2009
View Archived Issues
Ikaria, BioLineRx Enter Cardiac Licensing Deal Worth $282.5M
Ikaria Holdings Inc. has entered a deal worth a potential $282.5 million with Jerusalem-based BioLineRx Ltd. to license a cardiac remodeling product. (BioWorld Today)
Read More
OxiGene Frees up Cash, Product Rights in Low-Priced JV Buyout
Read More
Spectrum Spirals on Zevalin Complete Response Letter
Read More
FDA Query Gives Confidence to Protalix for Gaucher Drug
Read More
Novacta Gets $21M Backing for Antibiotics Development
Read More
NIH Finalizes Embryonic Stem Cell Funding Guidelines
Read More
Other News To Note
Read More
Clinic Roundup
Read More